VALNEVA SE - stock earnings
VLA.PA Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| Aug. 13, 2024 BeforeMarket | - / - | 43.9 million | - / 44.0 million | 44.2 million |
VLA.PA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | 58.9 million EUR | 32.8 million EUR |
| 2023Q4 | -32.2 million EUR | 41.9 million EUR |
| 2023Q3 | -34.2 million EUR | 38.1 million EUR |
| 2023Q2 | -16.9 million EUR | 40.2 million EUR |
| 2023Q1 | -18.1 million EUR | 33.5 million EUR |
| 2022Q4 | -44.2 million EUR | 111.4 million EUR |
| 2022Q3 | 72.4 million EUR | 156.7 million EUR |
| 2022Q2 | -145.5 million EUR | 71.4 million EUR |
| 2022Q1 | -26.0 million EUR | 21.8 million EUR |
| 2021Q4 | 172.5 million EUR | 278.2 million EUR |
| 2021Q3 | -159.5 million EUR | 22.3 million EUR |
| 2021Q2 | -58.7 million EUR | 24.3 million EUR |
| 2021Q1 | -27.7 million EUR | 23.2 million EUR |
| 2020Q4 | -2.1 million EUR | 51.5 million EUR |
| 2020Q3 | -36.7 million EUR | 10.9 million EUR |
| 2020Q2 | -24.4 million EUR | 12.7 million EUR |
| 2020Q1 | -1.2 million EUR | 35.2 million EUR |
| 2019Q4 | 690000 EUR | 44.8 million EUR |
| 2019Q3 | -33000 EUR | 26.9 million EUR |
| 2019Q2 | -7.3 million EUR | 19.7 million EUR |
| 2019Q1 | 4.9 million EUR | 34.9 million EUR |
| 2018Q4 | 6.5 million EUR | 34.7 million EUR |
| 2018Q3 | -3.1 million EUR | 19.4 million EUR |
| 2018Q2 | -1.7 million EUR | 26.9 million EUR |
| 2018Q1 | 1.5 million EUR | 32.1 million EUR |
| 2017Q4 | -3.7 million EUR | 28.9 million EUR |
| 2017Q3 | -3.4 million EUR | 22.5 million EUR |
| 2017Q2 | -2.7 million EUR | 25.4 million EUR |
| 2017Q1 | -1.7 million EUR | 28.4 million EUR |
| 2016Q4 | -2.7 million EUR | 26.0 million EUR |
| 2016Q3 | -7.0 million EUR | 18.4 million EUR |
| 2016Q2 | -34.4 million EUR | 25.9 million EUR |
| 2016Q1 | -5.0 million EUR | 23.7 million EUR |
| 2015Q4 | -779000 EUR | 20.9 million EUR |
| 2015Q3 | -5.9 million EUR | 20.2 million EUR |
| 2015Q2 | -9.0 million EUR | 18.6 million EUR |
| 2015Q1 | -5.0 million EUR | 18.6 million EUR |
| 2014Q4 | -11.5 million EUR | 11.5 million EUR |
| 2014Q3 | -2.6 million EUR | 11.1 million EUR |
| 2014Q2 | -5.1 million EUR | 8.1 million EUR |
| 2014Q1 | -7.1 million EUR | 6.3 million EUR |
| 2013Q4 | -6.0 million EUR | 8.9 million EUR |
| 2013Q3 | -10.0 million EUR | 13.8 million EUR |
| 2013Q2 | -5.6 million EUR | 7.0 million EUR |
| 2013Q1 | -2.5 million EUR | 737000 EUR |
| 2012Q4 | -4.9 million EUR | 895000 EUR |
| 2012Q3 | -2.4 million EUR | 1.0 million EUR |
| 2012Q2 | 1.8 million EUR | 45.8 million EUR |
| 2012Q1 | -10.8 million EUR | 8.0 million EUR |
VLA.PA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -101.4 million EUR | 153.7 million EUR |
| 2022 | -143.3 million EUR | 361.3 million EUR |
| 2021 | -73.4 million EUR | 348.1 million EUR |
| 2020 | -64.4 million EUR | 110.3 million EUR |
| 2019 | -1.7 million EUR | 126.2 million EUR |
| 2018 | 3.3 million EUR | 113.0 million EUR |
| 2017 | -11.5 million EUR | 105.3 million EUR |
| 2016 | -49.2 million EUR | 94.1 million EUR |
| 2015 | -20.6 million EUR | 78.4 million EUR |
| 2014 | -26.3 million EUR | 36.9 million EUR |
| 2013 | -24.1 million EUR | 30.4 million EUR |
| 2012 | -14.8 million EUR | 3.4 million EUR |
| 2011 | -4.4 million EUR | 10.3 million EUR |
| 2010 | -8.0 million EUR | 8.4 million EUR |
| 2009 | -6.1 million EUR | 3.1 million EUR |
| 2008 | -2.4 million EUR | 3.4 million EUR |
| 2007 | -3.4 million EUR | 866000 EUR |
| 2006 | -243000 EUR | 2.3 million EUR |
| 2005 | -1.2 million EUR | 3.0 million EUR |
VLA.PA
Price: €3.90
52 week price:
Earnings Per Share: -0.19 EUR
P/E Ratio: -4.46
Exchange: PAR
Sector: Healthcare
Industry: Biotechnology
Volume: 278769
Market Capitalization: 566.6 million